Middle-East and Africa Stroke Diagnosis and Treatment Market- Forecast to 2030

Middle-East and Africa Stroke Diagnosis and Treatment market information, by Type (Ischemic strokes, Hemorrhagic strokes, and other) by Diagnosis (Blood tests, Computerized tomography scan, Magnetic resonance imaging, Carotid ultrasound, Cerebral angiogram, Echocardiogram, and Others), by Treatment type (Cerebral thrombosis, Surgical clipping, endovascular embolization, Angioplasty and stents, Surgical AVM removal, Intracranial bypass, Stereotactic radiosurgery, and others) - Forecast to 2030

ID: MRFR/MED/1958-HCR | February 2023 | Region: Global | 60 Pages         

Stroke Diagnosis and Treatment Market Speak to Analyst Request a Free Sample

Middle-East and Africa Stroke Diagnosis and Treatment Market

Middle-East and Africa Stroke Diagnosis and Treatment market Is Projected To Reach USD 289.7 million, at a CAGR Of 6.5% By 2030.

Segmentation
By Type Ischemic strokes Hemorrhagic strokes other
By Diagnosis Blood tests Computerized tomography scan Magnetic resonance imaging Carotid ultrasound Cerebral angiogram Echocardiogram
By Treatment type Cerebral thrombosis Surgical clipping endovascular embolization Angioplasty and stents Surgical AVM removal
Key Players
Companies Profiled   King Faisal Specialist Hospital and Research Centre (Saudi Arabia)   Riyadh Military Hospital (Saudi Arabia)   Hamad Medical Corporation (Qatar)   American Hospital Dubai
Drivers
Market Driving Forces   Huge funding in R&D    Rising number of individuals at risk of stroke around the world
Request a Free Sample

Market Synopsis of Middle-East and Africa Stroke Diagnosis and Treatment Market:


The Stroke Diagnosis and Treatment Market Size to reach a CAGR of 6.5% and a value of USD 289.7 million from 2022 to 2030.


The rising number of individuals at risk of stroke around the world is a primary factor driving stroke diagnostics and treatments. High blood pressure is more common in the world's population, which is a major risk factor for stroke. Adults have high blood pressure, which is rapidly rising. The senior population is growing in emerging nations and is a risk of stroke individuals. Furthermore, smoking, diabetes, high cholesterol, physical inactivity, obesity, and carotid or other arterial disease are all substantial risk factors for stroke. As a result of these causes, there is a high demand for the Stroke Diagnosis and Treatment Market. 


The higher healthcare expenditure is a factor boosting the growth of the global market. Developed countries like U.S., Canada, Germany, and U.K. are spending huge investments on healthcare each year. With the increasing awareness of individuals across the globe regarding better health outcomes, increasing per capita income tends to raise the level of health expenditures worldwide. Furthermore, health deteriorates, and healthcare spending is growing old age population across the globe, which, in turn, tends to support the growth of the global stroke diagnostics and therapeutics market. Moreover, private and public payer spending has also increased. 


Segments:  


Middle-East and Africa Stroke Diagnosis and Treatment market has been segmented on the basis of type which comprises Ischemic strokes, Hemorrhagic strokes, and others.  On the basis of diagnosis the market is segmented into Blood tests, Computerized tomography scan, Magnetic resonance imaging, Carotid ultrasound, Cerebral angiogram, Echocardiogram, and Others. On the basis of treatment it is segmented into Cerebral thrombosis, Surgical clipping, endovascular embolization, Angioplasty and stents, Surgical AVM removal, Intracranial bypass, Stereotactic radiosurgery, and others.

Regional Analysis of Middle-East and Africa Stroke Diagnosis and Treatment Market:   


Considering the Middle-East and Africa Stroke Diagnosis and Treatment Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Stroke Diagnosis and Treatment. Moreover Saudi Arabia market is also growing and it is a second largest market for Stroke Diagnosis and Treatment. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Stroke Diagnosis and Treatment during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.


Recent Development


In May 2022


Royal Philips, a leader in health technology, will showcase its latest advances in its integrated suite of solutions for treating stroke patients at the 2022 European Stroke Organisation Conference. With its suite of solutions, Philips connects information, technologies enabling care teams to work quickly and act decisively.


In May 2022


MedTech company EMVision (ASX: EMV) has signed an exclusive 12-month agreement with Keysight Technologies (NYSE: KEYS) for the use of its "fast sweep" technology, providing the business with a "substantial competitive advantage."


The deal enables the Brisbane-based company to reduce the size of its breakthrough neuroimaging device, which uses electromagnetic microwave to diagnose and monitor stroke and other neurological disorders to be used in intensive care units (ICUs) ambulances.


Key Players for Middle-East and Africa Stroke Diagnosis and Treatment Market:   Some of the key players in this market are: King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), Abbott (US), Johnson & Johnson Services, Inc. (US), GE Healthcare (UK), Koninklijke Philips N.V. (Netherlands), Hitachi, Ltd. (Japan)


The report for Middle-East and Africa Stroke Diagnosis and Treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regionsStudy objectives of Middle-East and Africa Stroke Diagnosis and Treatment Market:



  • To provide detailed analysis of the market structure along with forecast for the next 5 years of the various segments and sub-segments of the Middle-East and Africa Stroke Diagnosis and Treatment market

  • To provide insights about factors affecting the market growth

  • To analyze the Middle-East and Africa Stroke Diagnosis and Treatment market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to two main geographies and their countries- Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by type, by diagnosis, by treatment type and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Middle-East and Africa Stroke Diagnosis and Treatment market.


Middle-East and Africa Stroke Diagnosis and Treatment market by Type Stroke Diagnosis and Treatment Market


Intended Audience



  • Middle-East and Africa Stroke Diagnosis and Treatment Equipment manufacturers

  • Middle-East and Africa Stroke Diagnosis and Treatment Equipment Suppliers

  • Government and Independent Regulatory Authorities

  • Research and Development (R&D) Companies

  • Independent Research Laboratories

  • Market Research and Consulting Service Providers

  • Medical Research Laboratories



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 289.7 million: 2030
  CAGR   6.5 %: 2030
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD million)
  Report Coverage    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment type, Application and End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt),
  Key Market Opportunities   health deteriorates, and healthcare spending is growing old age population across the globe,
  Key Market Drivers   rising number of individuals at risk of stroke around the world


Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

The Middle East and Africa Stroke Diagnosis and Treatment Market is projected to grow at a 6.5% CAGR between 2022-2030.

The Middle East and Africa Stroke Diagnosis and Treatment Market is predicted to touch USD 289.7 million by 2030.

The UAE is predicted to dominate the Middle East and Africa Stroke Diagnosis and Treatment Market.

Key competitors in the Middle East and Africa Stroke Diagnosis and Treatment Market include Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherlands), GE Healthcare (UK), Johnson & Johnson Services, Inc. (US), Abbott (US), Ganzouri Specialized Hospital (Egypt), American Hospital Dubai, Hamad Medical Corporation (Qatar), Riyadh Military Hospital (Saudi Arabia), and King Faisal Specialist Hospital and Research Centre (Saudi Arabia).

Key strategies incorporated by market players to create a dominance in the Middle East and Africa Stroke Diagnosis and Treatment Market include mergers, acquisitions, collaborations, and product development.